drugset / Trial / NCT05585983

INfluenza VaccInation To Mitigate typE 1 Diabetes

NCT05585983

Phase 4 Recruiting 100 enrolled Aarhus University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.

Timeline

Start
2022-12-14
Primary completion
2026-05-01
Completion
2027-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject NITRAMINE Vaccine 15 ug
Subject NITRAMINE Vaccine 0.5 ml